EA200401293A1 - Новое сочетание антитромботического агента и аспирина - Google Patents

Новое сочетание антитромботического агента и аспирина

Info

Publication number
EA200401293A1
EA200401293A1 EA200401293A EA200401293A EA200401293A1 EA 200401293 A1 EA200401293 A1 EA 200401293A1 EA 200401293 A EA200401293 A EA 200401293A EA 200401293 A EA200401293 A EA 200401293A EA 200401293 A1 EA200401293 A1 EA 200401293A1
Authority
EA
Eurasian Patent Office
Prior art keywords
aspirin
new combination
thrombotic agent
agent
thrombotic
Prior art date
Application number
EA200401293A
Other languages
English (en)
Other versions
EA006978B1 (ru
Inventor
Тони Вербеурен
Жильбер Лавьелль
Бернар Симетьер
Мари-Одиль Валле
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200401293A1 publication Critical patent/EA200401293A1/ru
Publication of EA006978B1 publication Critical patent/EA006978B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится к новому сочетанию антитромботического агента и аспирина и к фармацевтическим композициям, которые их включают.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200401293A 2002-04-05 2003-04-04 Новое сочетание антитромботического агента и аспирина EA006978B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine
PCT/FR2003/001054 WO2003084525A1 (fr) 2002-04-05 2003-04-04 Nouvelle association d'un antithrombotique et d'aspirine

Publications (2)

Publication Number Publication Date
EA200401293A1 true EA200401293A1 (ru) 2005-02-24
EA006978B1 EA006978B1 (ru) 2006-06-30

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401293A EA006978B1 (ru) 2002-04-05 2003-04-04 Новое сочетание антитромботического агента и аспирина

Country Status (27)

Country Link
US (1) US7618955B2 (ru)
EP (1) EP1496884B1 (ru)
JP (1) JP4065853B2 (ru)
KR (1) KR100645143B1 (ru)
CN (1) CN1297265C (ru)
AR (1) AR039253A1 (ru)
AT (1) ATE329591T1 (ru)
AU (1) AU2003246774B2 (ru)
BR (1) BR0309019A (ru)
CA (1) CA2480697A1 (ru)
CY (1) CY1105106T1 (ru)
DE (1) DE60306133T2 (ru)
DK (1) DK1496884T3 (ru)
EA (1) EA006978B1 (ru)
ES (1) ES2264533T3 (ru)
FR (1) FR2838057B1 (ru)
GE (1) GEP20074101B (ru)
HK (1) HK1076034A1 (ru)
MA (1) MA27114A1 (ru)
MX (1) MXPA04009760A (ru)
NO (1) NO20044700L (ru)
NZ (1) NZ535430A (ru)
PL (1) PL371620A1 (ru)
PT (1) PT1496884E (ru)
UA (1) UA79457C2 (ru)
WO (1) WO2003084525A1 (ru)
ZA (1) ZA200407593B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080017489A (ko) * 2005-07-22 2008-02-26 더 프록터 앤드 갬블 캄파니 약물 유발성 부정맥 발생률 감소용 조성물
CN103071154A (zh) 2007-04-13 2013-05-01 千年药品公司 用起因子xa抑制剂作用的化合物的组合抗凝治疗
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
HK1076034A1 (en) 2006-01-06
CA2480697A1 (fr) 2003-10-16
US7618955B2 (en) 2009-11-17
UA79457C2 (en) 2007-06-25
DE60306133T2 (de) 2007-01-04
CY1105106T1 (el) 2009-11-04
PT1496884E (pt) 2006-09-29
KR100645143B1 (ko) 2006-11-10
JP2005528376A (ja) 2005-09-22
DE60306133D1 (de) 2006-07-27
US20050143354A1 (en) 2005-06-30
AU2003246774A1 (en) 2003-10-20
AR039253A1 (es) 2005-02-16
WO2003084525A1 (fr) 2003-10-16
GEP20074101B (en) 2007-05-10
ZA200407593B (en) 2006-07-26
NO20044700L (no) 2004-10-29
EP1496884A1 (fr) 2005-01-19
EA006978B1 (ru) 2006-06-30
MXPA04009760A (es) 2004-12-13
CN1297265C (zh) 2007-01-31
FR2838057B1 (fr) 2005-07-08
CN1646111A (zh) 2005-07-27
NZ535430A (en) 2006-09-29
MA27114A1 (fr) 2004-12-20
FR2838057A1 (fr) 2003-10-10
KR20040098053A (ko) 2004-11-18
EP1496884B1 (fr) 2006-06-14
ES2264533T3 (es) 2007-01-01
PL371620A1 (en) 2005-06-27
ATE329591T1 (de) 2006-07-15
AU2003246774B2 (en) 2007-02-15
BR0309019A (pt) 2005-02-01
JP4065853B2 (ja) 2008-03-26
DK1496884T3 (da) 2006-10-02

Similar Documents

Publication Publication Date Title
EA200000768A1 (ru) ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
EA199900373A2 (ru) Фармацевтические композиции
EA200301250A1 (ru) Фармацевтические композиции, содержащие слаборастворимые и/или чувствительные к кислотам лекарственные средства и нейтрализованные кислотные полимеры
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
SE0301653D0 (sv) Novel compounds
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
EA200500442A1 (ru) Композиции и наборы для удаления раздражающих соединений с поверхностей тела
EA200300178A1 (ru) Смеси полисахаридов на основе гепарина, их получение и фармацевтические композиции, их содержащие
EA200201252A1 (ru) Соединения, эффективные в качестве агонистов э2 - адренорецептора и ингибиторов фосфодиэстеразы pde4
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
SE9901077D0 (sv) Novel use
MXPA03010158A (es) Sulfonamidas.
MA27889A1 (fr) Comprime contenant de la fluvastatine et de la carmellose calcique
EA200501341A1 (ru) Противобактериальные индолоноксазолидиноны, промежуточные соединения для их получения и содержащие их фармацевтические композиции
SE9801494D0 (sv) Novel use
UY27610A1 (es) Combinación de inhibidores de ptm o inhibidores de la secreción de apob con fibratos para la utilización como medicamentos
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU